Onglyza (saxagliptin) is an oral medication prescribed to help control blood sugar levels in Type-2 diabetes patients. Made by Bristol-Myers Squibb (Bristol) and AstraZeneca, Onglyza was approved by the U.S. Food and Drug Administration (FDA) in July 2009.1 Since then, Onglyza has been linked to life-threatening complications.
If you or a loved one has been severely injured by Onglyza, the dangerous drug lawyers at the Amaro Law Firm are ready to discuss your situation and help you get on the path to recovery and justice. Experienced and tenacious, we will aggressively advocate your rights, help you pursue all available legal remedies and work diligently.
While compensation can never reverse a permanent loss or injury caused by Onglyza, financial recoveries from these claims can be the key to restoring lives.